Having trouble accessing articles? Reset your cache.

Ampyra dalfampridine: Phase II data

Top-line data from a double-blind, crossover, U.S. Phase II trial in 83 patients who had experienced an ischemic stroke >=6 months prior to enrollment and who had chronic motor deficits

Read the full 302 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE